E L Arcinue Picu Medical Corporation is categorized under Artists Agents in Pasadena, CA and active since 1985.
E L Arcinue Picu Medical Corporation was established in 1985, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Artists Agents business, which does work in the B2B market, and is classified as a Artists Agents, under code number 711410 by the NAICS.
If you are seeking more information, feel free to contact Edgardo L Arcinue at the company’s single location by writing to 1145 Hillcrest Avenue, Pasadena, California CA 91106 or by phoning (626) 792-4572. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | E L Arcinue Picu Medical Corporation |
Contact Person: | Edgardo L Arcinue |
Address: | 1145 Hillcrest Avenue, Pasadena, California 91106 |
Phone Number: | (626) 792-4572 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Artists Agents |
SIC Code: | 7389 |
NAICS Code: | 711410 |
Share This Business: |
E L Arcinue Picu Medical Corporation was started in 1985 to provide professional Artists Agents under the SIC code 7389 and NAICS code 711410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Edgardo L Arcinue for inquiries that concern E L Arcinue Picu Medical Corporation by calling the company number (626) 792-4572, as your correspondence is most welcome. Additionally, the physical location of the single location of E L Arcinue Picu Medical Corporation can be found at the coordinates 34.127244,-118.134223 as well as the street address 1145 Hillcrest Avenue in Pasadena, California 91106.
For its online presence, you may visit E L Arcinue Picu Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.